5TUU image
Entry Detail
PDB ID:
5TUU
Keywords:
Title:
Crystal structure of the E2F4-DP1 coiled coil and marked-box domains
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2016-11-07
Release Date:
2017-05-03
Method Details:
Experimental Method:
Resolution:
2.25 Å
R-Value Free:
0.23
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
I 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Transcription factor DP1
Chain IDs:A
Chain Length:155
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Transcription factor E2F4
Chain IDs:B
Chain Length:111
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family.
Proc. Natl. Acad. Sci. U.S.A. 114 4942 4947 (2017)
PMID: 28439018 DOI: 10.1073/pnas.1619170114

Abstact

The retinoblastoma protein (Rb) and the homologous pocket proteins p107 and p130 negatively regulate cell proliferation by binding and inhibiting members of the E2F transcription factor family. The structural features that distinguish Rb from other pocket proteins have been unclear but are critical for understanding their functional diversity and determining why Rb has unique tumor suppressor activities. We describe here important differences in how the Rb and p107 C-terminal domains (CTDs) associate with the coiled-coil and marked-box domains (CMs) of E2Fs. We find that although CTD-CM binding is conserved across protein families, Rb and p107 CTDs show clear preferences for different E2Fs. A crystal structure of the p107 CTD bound to E2F5 and its dimer partner DP1 reveals the molecular basis for pocket protein-E2F binding specificity and how cyclin-dependent kinases differentially regulate pocket proteins through CTD phosphorylation. Our structural and biochemical data together with phylogenetic analyses of Rb and E2F proteins support the conclusion that Rb evolved specific structural motifs that confer its unique capacity to bind with high affinity those E2Fs that are the most potent activators of the cell cycle.

Legend

Protein

Chemical

Disease

Primary Citation of related structures